<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33170804</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1558-8238</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>04</Day></PubDate></JournalIssue><Title>The Journal of clinical investigation</Title><ISOAbbreviation>J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e134565</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/JCI134565</ELocationID><ELocationID EIdType="pii" ValidYN="Y">134565</ELocationID><Abstract><AbstractText>Polyglutamine (polyQ) diseases are devastating, slowly progressing neurodegenerative conditions caused by expansion of polyQ-encoding CAG repeats within the coding regions of distinct, unrelated genes. In spinal and bulbar muscular atrophy (SBMA), polyQ expansion within the androgen receptor (AR) causes progressive neuromuscular toxicity, the molecular basis of which is unclear. Using quantitative proteomics, we identified changes in the AR interactome caused by polyQ expansion. We found that the deubiquitinase USP7 preferentially interacts with polyQ-expanded AR and that lowering USP7 levels reduced mutant AR aggregation and cytotoxicity in cell models of SBMA. Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models, and monoallelic knockout of Usp7 ameliorated several motor deficiencies in transgenic SBMA mice. USP7 overexpression resulted in reduced AR ubiquitination, indicating the direct action of USP7 on AR. Using quantitative proteomics, we identified the ubiquitinated lysine residues on mutant AR that are regulated by USP7. Finally, we found that USP7 also differentially interacts with mutant Huntingtin (HTT) protein in striatum and frontal cortex of a knockin mouse model of Huntington's disease. Taken together, our findings reveal a critical role for USP7 in the pathophysiology of SBMA and suggest a similar role in SCA3 and Huntington's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pluciennik</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molotsky</LastName><ForeName>Elana</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsh</LastName><ForeName>Gregory B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranxhi</LastName><ForeName>Bedri</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Frederick J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St-Cyr</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>Beverly</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pourshafie</LastName><ForeName>Naemeh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>George Washington University, Institute of Biomedical Sciences, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology and Institute for Cancer Genetics, Columbia University, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todi</LastName><ForeName>Sokol V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merry</LastName><ForeName>Diane E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS086778</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS108114</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS055746</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA056036</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS090335</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 NS103060</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Invest</MedlineTA><NlmUniqueID>7802877</NlmUniqueID><ISSNLinking>0021-9738</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D000076084">Ubiquitin-Specific Peptidase 7</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="C504243">Usp7 protein, rat</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017827" MajorTopicYN="N">Machado-Joseph Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016716" MajorTopicYN="N">PC12 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076084" MajorTopicYN="N">Ubiquitin-Specific Peptidase 7</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Neuromuscular disease</Keyword><Keyword MajorTopicYN="N">Neuroscience</Keyword><Keyword MajorTopicYN="N">Ubiquitin-proteosome system</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> The authors have declared that no conflict of interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>10</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33170804</ArticleId><ArticleId IdType="pmc">PMC7773404</ArticleId><ArticleId IdType="doi">10.1172/JCI134565</ArticleId><ArticleId IdType="pii">134565</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen ES, et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci. 2004;24(20):4778&#x2013;4786. doi: 10.1523/JNEUROSCI.0808-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0808-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35(5):843&#x2013;854. doi: 10.1016/S0896-6273(02)00834-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00834-6</ArticleId><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, et al. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest. 2006;116(10):2663&#x2013;2672. doi: 10.1172/JCI28773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI28773</ArticleId><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18(7):671&#x2013;680. doi: 10.1212/WNL.18.7.671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.18.7.671</ArticleId><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain. 1989;112(Pt 1):209&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 2014;7(3):774&#x2013;784. doi: 10.1016/j.celrep.2014.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, et al. Defects in neuromuscular transmission may underlie motor dysfunction in spinal and bulbar muscular atrophy. J Neurosci. 2016;36(18):5094&#x2013;5106. doi: 10.1523/JNEUROSCI.3485-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3485-15.2016</ArticleId><ArticleId IdType="pmc">PMC4854970</ArticleId><ArticleId IdType="pubmed">27147661</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol. 1998;44(2):249&#x2013;254. doi: 10.1002/ana.410440216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440216</ArticleId><ArticleId IdType="pubmed">9708548</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am J Pathol. 1998;153(3):695&#x2013;701. doi: 10.1016/S0002-9440(10)65612-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)65612-X</ArticleId><ArticleId IdType="pmc">PMC1853004</ArticleId><ArticleId IdType="pubmed">9736019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohen SP, Kralli A, Yamamoto KR. Hold &#x2018;em and fold &#x2018;em: chaperones and signal transduction. Science. 1995;268(5215):1303&#x2013;1304. doi: 10.1126/science.7761850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7761850</ArticleId><ArticleId IdType="pubmed">7761850</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano LQ, Lavery DN, Bevan CL. Mini-review: Foldosome regulation of androgen receptor action in prostate cancer. Mol Cell Endocrinol. 2013;369(1&#x2013;2):52&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">23395916</ArticleId></ArticleIdList></Reference><Reference><Citation>Cato L, Neeb A, Brown M, Cato AC. Control of steroid receptor dynamics and function by genomic actions of the cochaperones p23 and Bag-1L. Nucl Recept Signal. 2014;12:e005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4242288</ArticleId><ArticleId IdType="pubmed">25422595</ArticleId></ArticleIdList></Reference><Reference><Citation>Black BE, Holaska JM, Rastinejad F, Paschal BM. DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr Biol. 2001;11(22):1749&#x2013;1758. doi: 10.1016/S0960-9822(01)00537-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(01)00537-1</ArticleId><ArticleId IdType="pubmed">11719216</ArticleId></ArticleIdList></Reference><Reference><Citation>Shank LC, et al. Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro. J Biol Chem. 2008;283(16):10568&#x2013;10580. doi: 10.1074/jbc.M800810200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800810200</ArticleId><ArticleId IdType="pmc">PMC7486792</ArticleId><ArticleId IdType="pubmed">18270197</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M, Pennuto M. Serine phosphorylation and arginine methylation at the crossroads to neurodegeneration. Exp Neurol. 2015;271:77&#x2013;83. doi: 10.1016/j.expneurol.2015.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.05.003</ArticleId><ArticleId IdType="pubmed">25979114</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua JP, et al. Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease. J Clin Invest. 2015;125(2):831&#x2013;845. doi: 10.1172/JCI73214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI73214</ArticleId><ArticleId IdType="pmc">PMC4319414</ArticleId><ArticleId IdType="pubmed">25607844</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie HL, Pestell RG, Merry DE. SIRT1 modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA. J Neurosci. 2011;31(48):17425&#x2013;17436. doi: 10.1523/JNEUROSCI.3958-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3958-11.2011</ArticleId><ArticleId IdType="pmc">PMC6088793</ArticleId><ArticleId IdType="pubmed">22131404</ArticleId></ArticleIdList></Reference><Reference><Citation>He B, et al. An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP) J Biol Chem. 2004;279(29):30643&#x2013;30653. doi: 10.1074/jbc.M403117200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M403117200</ArticleId><ArticleId IdType="pubmed">15107424</ArticleId></ArticleIdList></Reference><Reference><Citation>Morishima Y, Wang AM, Yu Z, Pratt WB, Osawa Y, Lieberman AP. CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins. Hum Mol Genet. 2008;17(24):3942&#x2013;3952. doi: 10.1093/hmg/ddn296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn296</ArticleId><ArticleId IdType="pmc">PMC2605787</ArticleId><ArticleId IdType="pubmed">18784277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 2002;21(15):4037&#x2013;4048. doi: 10.1093/emboj/cdf406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdf406</ArticleId><ArticleId IdType="pmc">PMC126152</ArticleId><ArticleId IdType="pubmed">12145204</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawaz Z, et al. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol. 1999;19(2):1182&#x2013;1189. doi: 10.1128/MCB.19.2.1182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.19.2.1182</ArticleId><ArticleId IdType="pmc">PMC116047</ArticleId><ArticleId IdType="pubmed">9891052</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K, et al. Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell. 2009;15(4):270&#x2013;282. doi: 10.1016/j.ccr.2009.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2009.02.021</ArticleId><ArticleId IdType="pmc">PMC2848969</ArticleId><ArticleId IdType="pubmed">19345326</ArticleId></ArticleIdList></Reference><Reference><Citation>Burska UL, et al. Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptor. J Biol Chem. 2013;288(45):32641&#x2013;32650. doi: 10.1074/jbc.M113.485912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.485912</ArticleId><ArticleId IdType="pmc">PMC3820899</ArticleId><ArticleId IdType="pubmed">24056413</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirac AM, Bernards R. The deubiquitinating enzyme USP26 is a regulator of androgen receptor signaling. Mol Cancer Res. 2010;8(6):844&#x2013;854. doi: 10.1158/1541-7786.MCR-09-0424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-09-0424</ArticleId><ArticleId IdType="pubmed">20501646</ArticleId></ArticleIdList></Reference><Reference><Citation>Faus H, Meyer HA, Huber M, Bahr I, Haendler B. The ubiquitin-specific protease USP10 modulates androgen receptor function. Mol Cell Endocrinol. 2005;245(1&#x2013;2):138&#x2013;146. doi: 10.1016/j.mce.2005.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2005.11.011</ArticleId><ArticleId IdType="pubmed">16368182</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ST, Okada M, Nakato R, Izumi K, Bando M, Shirahige K. The deubiquitinating enzyme USP7 regulates androgen receptor activity by modulating its binding to chromatin. J Biol Chem. 2015;290(35):21713&#x2013;21723. doi: 10.1074/jbc.M114.628255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.628255</ArticleId><ArticleId IdType="pmc">PMC4571893</ArticleId><ArticleId IdType="pubmed">26175158</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgetti E, Lieberman AP. Polyglutamine androgen receptor-mediated neuromuscular disease. Cell Mol Life Sci. 2016;73(21):3991&#x2013;3999. doi: 10.1007/s00018-016-2275-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2275-1</ArticleId><ArticleId IdType="pmc">PMC5045769</ArticleId><ArticleId IdType="pubmed">27188284</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431(7010):805&#x2013;810. doi: 10.1038/nature02998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02998</ArticleId><ArticleId IdType="pubmed">15483602</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman AB, Yoo SY, Dantuma NP, Zoghbi HY. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet. 2005;14(5):679&#x2013;691. doi: 10.1093/hmg/ddi064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi064</ArticleId><ArticleId IdType="pubmed">15661755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega Z, Diaz-Hernandez M, Maynard CJ, Hernandez F, Dantuma NP, Lucas JJ. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation. J Neurosci. 2010;30(10):3675&#x2013;3688. doi: 10.1523/JNEUROSCI.5673-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5673-09.2010</ArticleId><ArticleId IdType="pmc">PMC6632247</ArticleId><ArticleId IdType="pubmed">20220001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YE, et al. Soluble oligomers of polyQ-expanded Huntingtin target a multiplicity of key cellular factors. Mol Cell. 2016;63(6):951&#x2013;964. doi: 10.1016/j.molcel.2016.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.07.022</ArticleId><ArticleId IdType="pubmed">27570076</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine EM, Berger TR, Pluciennik A, Orr CR, Zboray L, Merry DE. Proteasome-mediated proteolysis of the polyglutamine-expanded androgen receptor is a late event in spinal and bulbar muscular atrophy (SBMA) pathogenesis. J Biol Chem. 2015;290(20):12572&#x2013;12584. doi: 10.1074/jbc.M114.617894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.617894</ArticleId><ArticleId IdType="pmc">PMC4432278</ArticleId><ArticleId IdType="pubmed">25795778</ArticleId></ArticleIdList></Reference><Reference><Citation>Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 1998;95(1):55&#x2013;66. doi: 10.1016/S0092-8674(00)81782-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81782-1</ArticleId><ArticleId IdType="pubmed">9778247</ArticleId></ArticleIdList></Reference><Reference><Citation>Simeoni S, et al. Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet. 2000;9(1):133&#x2013;144. doi: 10.1093/hmg/9.1.133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.1.133</ArticleId><ArticleId IdType="pubmed">10587588</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson HL, Bonini NM, Roth KA. Polyglutamine disease and neuronal cell death. Proc Natl Acad Sci U S A. 2000;97(24):12957&#x2013;12958. doi: 10.1073/pnas.210395797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.210395797</ArticleId><ArticleId IdType="pmc">PMC34075</ArticleId><ArticleId IdType="pubmed">11058149</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson AL, Bottomley SP. Towards the treatment of polyglutamine diseases: the modulatory role of protein context. Curr Med Chem. 2010;17(27):3058&#x2013;3068. doi: 10.2174/092986710791959800.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986710791959800</ArticleId><ArticleId IdType="pubmed">20629626</ArticleId></ArticleIdList></Reference><Reference><Citation>Culver BP, et al. Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis. J Biol Chem. 2012;287(26):21599&#x2013;21614. doi: 10.1074/jbc.M112.359307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.359307</ArticleId><ArticleId IdType="pmc">PMC3381125</ArticleId><ArticleId IdType="pubmed">22556411</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp F, et al. Quantitative interaction proteomics of neurodegenerative disease proteins. Cell Rep. 2015;11(7):1134&#x2013;1146. doi: 10.1016/j.celrep.2015.04.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.04.030</ArticleId><ArticleId IdType="pubmed">25959826</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J, et al. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature. 2008;452(7188):713&#x2013;718. doi: 10.1038/nature06731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06731</ArticleId><ArticleId IdType="pmc">PMC2377396</ArticleId><ArticleId IdType="pubmed">18337722</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchemin AM, Gottlieb B, Beitel LK, Elhaji YA, Pinsky L, Trifiro MA. Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy. Brain Res Bull. 2001;56(3&#x2013;4):285&#x2013;297. doi: 10.1016/S0361-9230(01)00583-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0361-9230(01)00583-4</ArticleId><ArticleId IdType="pubmed">11719263</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki E, et al. Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity. Proc Natl Acad Sci U S A. 2009;106(10):3818&#x2013;3822. doi: 10.1073/pnas.0809819106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0809819106</ArticleId><ArticleId IdType="pmc">PMC2656163</ArticleId><ArticleId IdType="pubmed">19237573</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H, et al. A polyglutamine expansion disease protein sequesters PTIP to attenuate DNA repair and increase genomic instability. Hum Mol Genet. 2012;21(19):4225&#x2013;4236. doi: 10.1093/hmg/dds246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds246</ArticleId><ArticleId IdType="pmc">PMC3441122</ArticleId><ArticleId IdType="pubmed">22736030</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P, Watt K, Kelly SM, Clark C, Price NC, McEwan IJ. Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain. J Mol Endocrinol. 2008;41(5):301&#x2013;314. doi: 10.1677/JME-08-0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/JME-08-0042</ArticleId><ArticleId IdType="pubmed">18762554</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekharzadeh B, et al. Sequence context influences the structure and aggregation behavior of a polyQ tract. Biophys J. 2016;110(11):2361&#x2013;2366. doi: 10.1016/j.bpj.2016.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2016.04.022</ArticleId><ArticleId IdType="pmc">PMC4900447</ArticleId><ArticleId IdType="pubmed">27276254</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie HL, et al. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet. 2009;18(11):1937&#x2013;1950. doi: 10.1093/hmg/ddp115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp115</ArticleId><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr CR, et al. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. J Biol Chem. 2010;285(46):35567&#x2013;35577. doi: 10.1074/jbc.M110.146845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.146845</ArticleId><ArticleId IdType="pmc">PMC2975181</ArticleId><ArticleId IdType="pubmed">20826791</ArticleId></ArticleIdList></Reference><Reference><Citation>Walcott JL, Merry DE. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J Biol Chem. 2002;277(52):50855&#x2013;50859. doi: 10.1074/jbc.M209466200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209466200</ArticleId><ArticleId IdType="pubmed">12388541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zboray L, et al. Preventing the androgen receptor N/C interaction delays disease onset in a mouse model of SBMA. Cell Rep. 2015;13(10):2312&#x2013;2323. doi: 10.1016/j.celrep.2015.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.11.019</ArticleId><ArticleId IdType="pmc">PMC4684905</ArticleId><ArticleId IdType="pubmed">26673324</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J, et al. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol. 2011;7(12):925&#x2013;934. doi: 10.1038/nchembio.694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.694</ArticleId><ArticleId IdType="pmc">PMC3271120</ArticleId><ArticleId IdType="pubmed">22037470</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger TR, Montie HL, Jain P, Legleiter J, Merry DE. Identification of novel polyglutamine-expanded aggregation species in spinal and bulbar muscular atrophy. Brain Res. 2015;1628(Pt B):254&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4681586</ArticleId><ArticleId IdType="pubmed">26453288</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Brooks CL, Kon N, Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell. 2004;13(6):879&#x2013;886. doi: 10.1016/S1097-2765(04)00157-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(04)00157-1</ArticleId><ArticleId IdType="pubmed">15053880</ArticleId></ArticleIdList></Reference><Reference><Citation>Moses K, Rubin GM. Glass encodes a site-specific DNA-binding protein that is regulated in response to positional signals in the developing Drosophila eye. Genes Dev. 1991;5(4):583&#x2013;593. doi: 10.1101/gad.5.4.583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.5.4.583</ArticleId><ArticleId IdType="pubmed">2010085</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB, et al. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron. 2010;67(6):936&#x2013;952. doi: 10.1016/j.neuron.2010.08.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.08.034</ArticleId><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey UB, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007;447(7146):859&#x2013;863.</Citation><ArticleIdList><ArticleId IdType="pubmed">17568747</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou WL, et al. Systematic analysis of the physiological importance of deubiquitinating enzymes. PLoS One. 2012;7(8):e43112. doi: 10.1371/journal.pone.0043112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043112</ArticleId><ArticleId IdType="pmc">PMC3427330</ArticleId><ArticleId IdType="pubmed">22937016</ArticleId></ArticleIdList></Reference><Reference><Citation>Burr AA, Tsou WL, Ristic G, Todi SV. Using membrane-targeted green fluorescent protein to monitor neurotoxic protein-dependent degeneration of Drosophila eyes. J Neurosci Res. 2014;92(9):1100&#x2013;1109. doi: 10.1002/jnr.23395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23395</ArticleId><ArticleId IdType="pmc">PMC4144675</ArticleId><ArticleId IdType="pubmed">24798551</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton JR, et al. Interaction of the polyglutamine protein ataxin-3 with Rad23 regulates toxicity in Drosophila models of spinocerebellar ataxia type 3. Hum Mol Genet. 2017;26(8):1419&#x2013;1431. doi: 10.1093/hmg/ddx039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx039</ArticleId><ArticleId IdType="pmc">PMC6075452</ArticleId><ArticleId IdType="pubmed">28158474</ArticleId></ArticleIdList></Reference><Reference><Citation>Das B, et al. A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses &#x3b1;-syn- and MPTP-induced toxicities in vivo. Neuropharmacology. 2017;123:88&#x2013;99. doi: 10.1016/j.neuropharm.2017.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2017.05.019</ArticleId><ArticleId IdType="pmc">PMC5542047</ArticleId><ArticleId IdType="pubmed">28533164</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou WL, et al. DnaJ-1 and karyopherin &#x3b1;3 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6. Hum Mol Genet. 2015;24(15):4385&#x2013;4396. doi: 10.1093/hmg/ddv174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv174</ArticleId><ArticleId IdType="pmc">PMC4492400</ArticleId><ArticleId IdType="pubmed">25954029</ArticleId></ArticleIdList></Reference><Reference><Citation>Yedlapudi D, Joshi GS, Luo D, Todi SV, Dutta AK. Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model. Sci Rep. 2016;6:38510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5137034</ArticleId><ArticleId IdType="pubmed">27917933</ArticleId></ArticleIdList></Reference><Reference><Citation>Menalled LB, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington&#x2019;s disease: zQ175. PLoS One. 2012;7(12):e49838. doi: 10.1371/journal.pone.0049838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049838</ArticleId><ArticleId IdType="pmc">PMC3527464</ArticleId><ArticleId IdType="pubmed">23284626</ArticleId></ArticleIdList></Reference><Reference><Citation>Kon N, Kobayashi Y, Li M, Brooks CL, Ludwig T, Gu W. Inactivation of HAUSP in vivo modulates p53 function. Oncogene. 2010;29(9):1270&#x2013;1279. doi: 10.1038/onc.2009.427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2009.427</ArticleId><ArticleId IdType="pmc">PMC2857765</ArticleId><ArticleId IdType="pubmed">19946331</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter RJ, et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington&#x2019;s disease mutation. J Neurosci. 1999;19(8):3248&#x2013;3257. doi: 10.1523/JNEUROSCI.19-08-03248.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-08-03248.1999</ArticleId><ArticleId IdType="pmc">PMC6782264</ArticleId><ArticleId IdType="pubmed">10191337</ArticleId></ArticleIdList></Reference><Reference><Citation>Southwell AL, Ko J, Patterson PH. Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington&#x2019;s disease. J Neurosci. 2009;29(43):13589&#x2013;13602. doi: 10.1523/JNEUROSCI.4286-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4286-09.2009</ArticleId><ArticleId IdType="pmc">PMC2822643</ArticleId><ArticleId IdType="pubmed">19864571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao YH, et al. USP7 acts as a molecular rheostat to promote WASH-dependent endosomal protein recycling and is mutated in a human neurodevelopmental disorder. Mol Cell. 2015;59(6):956&#x2013;969. doi: 10.1016/j.molcel.2015.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.07.033</ArticleId><ArticleId IdType="pmc">PMC4575888</ArticleId><ArticleId IdType="pubmed">26365382</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 2002;416(6881):648&#x2013;653. doi: 10.1038/nature737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature737</ArticleId><ArticleId IdType="pubmed">11923872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey CK, Andriola IF, Kampinga HH, Merry DE. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum Mol Genet. 2002;11(5):515&#x2013;523. doi: 10.1093/hmg/11.5.515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.5.515</ArticleId><ArticleId IdType="pubmed">11875046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang AM, et al. Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation. Nat Chem Biol. 2013;9(2):112&#x2013;118. doi: 10.1038/nchembio.1140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1140</ArticleId><ArticleId IdType="pmc">PMC3552084</ArticleId><ArticleId IdType="pubmed">23222885</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao JJ, Smits MM, Ng BH, Lee J, Wright ME. Discovery Proteomics Identifies a Molecular Link between the Coatomer Protein Complex I and Androgen Receptor-dependent Transcription. J Biol Chem. 2016;291(36):18818&#x2013;18842. doi: 10.1074/jbc.M116.732313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.732313</ArticleId><ArticleId IdType="pmc">PMC5009256</ArticleId><ArticleId IdType="pubmed">27365400</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang T, Liao S. A very rapid effect of androgen on initiation of protein synthesis in prostate. Proc Natl Acad Sci U S A. 1975;72(2):706&#x2013;709. doi: 10.1073/pnas.72.2.706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.72.2.706</ArticleId><ArticleId IdType="pmc">PMC432384</ArticleId><ArticleId IdType="pubmed">1054848</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Montalv&#xe1;n A, et al. Biochemical characterization of USP7 reveals post-translational modification sites and structural requirements for substrate processing and subcellular localization. FEBS J. 2007;274(16):4256&#x2013;4270. doi: 10.1111/j.1742-4658.2007.05952.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2007.05952.x</ArticleId><ArticleId IdType="pubmed">17651432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata JM, Pawlowski K, Haas E, Ware CF, Godzik A, Reed JC. A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J Biol Chem. 2001;276(26):24242&#x2013;24252. doi: 10.1074/jbc.M100354200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M100354200</ArticleId><ArticleId IdType="pubmed">11279055</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya S, Chakraborty D, Basu M, Ghosh MK. Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases. Signal Transduct Target Ther. 2018;3:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6023882</ArticleId><ArticleId IdType="pubmed">29967688</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim RQ, Sixma TK. Regulation of USP7: a high incidence of E3 complexes. J Mol Biol. 2017;429(22):3395&#x2013;3408. doi: 10.1016/j.jmb.2017.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2017.05.028</ArticleId><ArticleId IdType="pubmed">28591556</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C, Vogelstein B. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature. 2004;428(6982):1&#x2013;2. doi: 10.1038/nature02501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02501</ArticleId><ArticleId IdType="pubmed">15058298</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TP, et al. Ubiquitin modulates liquid-liquid phase separation of UBQLN2 via disruption of multivalent interactions. Mol Cell. 2018;69(6):965&#x2013;978.e6. doi: 10.1016/j.molcel.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>An T, et al. USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth. Biochem Pharmacol. 2017;131:29&#x2013;39. doi: 10.1016/j.bcp.2017.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2017.02.011</ArticleId><ArticleId IdType="pubmed">28216017</ArticleId></ArticleIdList></Reference><Reference><Citation>Carra G, et al. Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones. Oncotarget. 2017;8(22):35508&#x2013;35522. doi: 10.18632/oncotarget.16348.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.16348</ArticleId><ArticleId IdType="pmc">PMC5482594</ArticleId><ArticleId IdType="pubmed">28418900</ArticleId></ArticleIdList></Reference><Reference><Citation>Morra F, et al. The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells. Oncotarget. 2017;8(19):31815&#x2013;31829. doi: 10.18632/oncotarget.16463.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.16463</ArticleId><ArticleId IdType="pmc">PMC5458250</ArticleId><ArticleId IdType="pubmed">28415632</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Kim SJ, Ka S, Choi I, Kang S. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product. Mol Cell Neurosci. 2002;20(2):298&#x2013;306. doi: 10.1006/mcne.2002.1103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.2002.1103</ArticleId><ArticleId IdType="pubmed">12093161</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>